ZHENG Shi-hua, CHEN Hua-wei. A Clinical Research on Treatment of Infant Recurrent Respiratory Infection with Combination of Traditional Chinese Medicine and Western Medicine[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(13): 342-345.
ZHENG Shi-hua, CHEN Hua-wei. A Clinical Research on Treatment of Infant Recurrent Respiratory Infection with Combination of Traditional Chinese Medicine and Western Medicine[J]. Chinese journal of experimental traditional medical formulae, 2013, 19(13): 342-345. DOI: 10.11653/syfj2013130342.
Objective:To investigate the effect of treatment of infant recurrent respiratory infection (RRTI) with combination of traditional Chinese medicine and Western medicine. Method: Ninety RRTI patients were randomly divided into observation group and control group (n=45 each). At attack stage
the two groups were received routine western medicine therapy. At remission stage
control group was orally received transfer factor oral solution
10 mL once daily
and observation group was orally treated with Huangqi Shengmai yin
10 mL twice daily and Shenlin Baizhu powder
1 agent daily (taken half by half). The treatment course of two groups was 8 weeks
and follow-up time lasted 6 months. Score of lung and spleen deficiency syndrome was observed
T-cell subsets and immunoglobulin were tested before and after treatment. Result: The total effective rate of observation group (97.77%) was higher than that of control group (66.66%) with a significant difference (P<0.01). The improvement of CD3+
CD4+
CD8+ and CD4+/CD8+ in observation group were better than those in control group (P<0.05
P<0.01). After treatment
IgG and IgA in observation group were increased significantly than those in control group (P<0.01). The syndrome score of lung and spleen deficiency in observation group were significantly lower than those in control group (P<0.01). Conclusion: Western medicine therapy
used at attack stage
combined with Huangqi Shengmai yin and Shenlin Baizhu powder
used at remission stage can improve physical condition of infected children
promote patient immunity
reduce clinical symptom and treat infant recurrent respiratory infection effectively.